GFACX
Price
$61.91
Change
-$1.33 (-2.10%)
Updated
Sep 6 closing price
HCAIX
Price
$100.66
Change
-$2.74 (-2.65%)
Updated
Sep 6 closing price
Ad is loading...

GFACX vs HCAIX

Header iconGFACX vs HCAIX Comparison
Open Charts GFACX vs HCAIXBanner chart's image
American Funds Growth Fund of Amer C
Price$61.91
Change-$1.33 (-2.10%)
VolumeN/A
CapitalizationN/A
Harbor Capital Appreciation I
Price$100.66
Change-$2.74 (-2.65%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
GFACX vs HCAIX Comparison Chart
Loading...
VS
GFACX vs. HCAIX commentary
Sep 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a Buy and HCAIX is a Buy.

FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 270B vs. HCAIX (27B). GFACX (0.00) and HCAIX (0.00) have matching dividends . GFACX was incepted earlier than HCAIX: GFACX (24 years) vs HCAIX (22 years). GFACX is a more actively managed with annual turnover of: 31.00 vs. HCAIX (27.00). GFACX has a lower initial minimum investment than HCAIX: GFACX (250) vs HCAIX (2500). HCAIX annual gain was more profitable for investors over the last year : 28.54 vs. GFACX (16.44). HCAIX return over 5 years is better than : 43.15 vs. GFACX (38.56).
GFACXHCAIXGFACX / HCAIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years22 years-
Gain YTD14.98216.35092%
Front LoadN/AN/A-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets270B27B1,000%
Annual Yield % from dividends0.000.00-
Returns for 1 year16.4428.5458%
Returns for 3 years-11.08-10.24108%
Returns for 5 years38.5643.1589%
Returns for 10 years42.4671.3360%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KW11.040.03
+0.27%
Kennedy-Wilson Holdings
CTVA55.11-0.39
-0.70%
Corteva
FIVN29.58-0.24
-0.80%
Five9
VEV0.14N/A
-1.68%
Vicinity Motor Corp
ADAP1.11-0.05
-4.31%
Adaptimmune Therapeutics plc